Johnson & Johnson announces US launch of TECNIS Odyssey IOL

News
Article

The TECNIS Odyssey IOL is a new full vision range IOL built on the TECNIS platform.

Odyssey IOL packaging Image credit: Johnson & Johnson

Image credit: Johnson & Johnson

Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL), TECNIS Odyssey, in the US.

The TECNIS Odyssey IOL is a new full vision range IOL, built on the TECNIS platform from Johnson & Johnson, which according to the company provides two times better contrast in low lighting than PanOptix.1

Peter Menziuso, company group chairman, Vision, Johnson & Johnson, commented on the launch in a release from the company stating, “More than 14,000 eyes have already benefited from TECNIS Odyssey, our new full visual range IOL. TECNIS Odyssey patients have reported outstanding visual outcomes following surgery, which is why we are excited to announce we are expanding the roll-out across the US. Cataract surgery gives patients a once-in-a-lifetime opportunity to improve their sight, and now with this advanced IOL, patients can see clearly at every distance, without the need for glasses.”

TECNIS Odyssey IOLs feature a unique, freeform diffractive surface designed to eliminate the gaps between near, intermediate, and far distances, which offers continuous, uninterrupted vision at all distances, according to the company. Furthermore, 94% of patients who received the IOL were satisfied with their overall vision without glasses.1

In addition to the launch, Johnson & Johnson is launching the “TECNIS Odyssey IOL Peer Connect" which will allow eye care professionals to engage in live virtual clinical discussions, and will help “foster direct and meaningful medical and scientific conversations regarding TECNIS Odyssey IOL between healthcare professionals with expert surgeons who had early access to the technology.”1

In addition to the US, TECNIS Odyssey IOLs have received regulatory approval in Japan, EU, Korea, Canada, Singapore, Australia and New Zealand.

References:
  1. Johnson & Johnson Rolls Out New TECNIS Odyssey Next-Generation Intraocular Lens Offering Cataract Patients Precise Vision at Every Distance in Any Lighting. Press Release; September 30, 2024. Accessed September 30, 2024. https://www2.multivu.com/johnson-johnson/9293351-en-johnson-and-johnson-vision-tecnis-odyssey

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
© 2025 MJH Life Sciences

All rights reserved.